Institutional members access full text with Ovid®

Share this article on:

Tuberculosis Prevention in HIV-Positive Adults with Latent Disease

Kuznar, Wayne; Kayyali, Andrea MSN, RN

AJN The American Journal of Nursing: November 2011 - Volume 111 - Issue 11 - p 59
doi: 10.1097/01.NAJ.0000407304.30716.5d
Journal Watch
  • Three new tuberculosis treatment strategies (12 weeks of rifapentine plus isoniazid, 12 weeks of rifampin plus isoniazid, or long-term isoniazid [as long as six years]) showed no greater effectiveness than a six-month course of isoniazid.
© 2011 Lippincott Williams & Wilkins, Inc.